Articles tagged with Myocardial Infarction
The CHILL-MI trial found that therapeutic hypothermia using intravenous cold saline and endovascular venous cooling reduced clinical heart failure incidence by 71% in STEMI patients. However, the trial missed its primary endpoint of reducing infarct size.
A recent study by Kaiser Permanente found that individuals with low recorded CD4 cell counts have a higher risk of heart attacks compared to HIV-negative subjects. However, those with high CD4 cell counts had the same risk as the general population.
A study published in the Journal of the American Medical Association found that flu shots reduced the risk of heart attack or stroke by 36-55% among patients with a history of heart disease. The vaccine's protective effects were greater in those who received a more potent vaccine.
New research led by Dr. Jacob Udell found that the flu vaccine reduces the risk of heart attack or stroke by over 50% among those who have had a heart attack. The study also suggests that the vaccine's heart-protective effects may be even greater among those who receive a more potent vaccine.
A UC San Francisco researcher recommends prioritizing dietary calcium intake over supplements to prevent osteoporosis and fractures. The recommended daily dose is 1,200 mg per day, with foods like dairy products, kale, broccoli, and Bok Choy providing essential calcium.
The Dartmouth Atlas report shows wide variation in prescription drug use among Medicare patients across US regions, with higher spending not related to proven treatment use. Effective therapies are underused in some areas, while potentially harmful medications are overprescribed.
Scientists have discovered that ticagrelor reduces the risk of dying from lung infection after a heart attack, with fewer deaths due to sepsis. The study found subtle differences in blood markers of immune cell activity between ticagrelor and clopidogrel treatment patients.
Research from Athens, Greece found that psychological interventions reduced mortality and cardiovascular events by 55% after 2 years or more in patients with coronary heart disease. The addition of psychological support improved patient outcomes by providing information, reassurance, and stress management techniques.
A study published in JAMA Internal Medicine compared the cardiovascular safety of conjugated equine estrogens (CEEs) and oral estradiol. The research found a greater risk of venous thrombosis associated with CEEs, but no increased risk of heart attack or ischemic stroke.
A new observational study suggests that bioidentical hormones in transdermal patches may be associated with a lower risk of heart attack, while FDA-approved products may carry a slightly lower risk of stroke compared to synthetic hormones. The findings are inconclusive and require confirmation by randomized trials.
A study by McGill University Health Centre found that one in five young women (under 55) experiencing a heart attack do not exhibit chest pain as a symptom. The absence of this common indicator did not correlate with reduced disease severity, highlighting the need for more nuanced assessments and training for healthcare professionals.
A study by researchers at Henry Ford Hospital found that patients with longer-lasting chest pain are more likely to have a heart attack. Patients with chest pain of short duration, less than 5 minutes, are unlikely to have a heart attack and have a good prognosis at 30 days.
A new study published in Radiology found that whole-body MRI can accurately predict the risk of heart attack and stroke in diabetic patients. The study revealed that patients with detectable vascular changes on whole-body MRI faced a cumulative risk rate of 20% at three years, increasing to 35% at six years.
A Binghamton University researcher has received funding to develop a more accurate way of determining a patient's risk of heart attack or stroke. The goal is to identify which plaques are stable and which ones are dangerous, allowing doctors to make informed decisions.
Researchers at The University of Manchester and medical institutes in Italy have identified a gene variant associated with vasospasm, a rare cause of heart attacks. This discovery could lead to the development of new drugs to treat this condition.
A team of scientists has developed a synthetic mRNA that induces self-repair and regeneration of the infarcted heart in mice. The study shows that this approach can lead to long-term therapeutic effects, including improved survival following myocardial infarction.
The European Society of Cardiology (ESC) Congress 2013 presented several significant studies on cardiovascular disease treatment, including new anticoagulants, heart attack therapies, and preventive measures. The event also highlighted the need for better healthcare access and policy changes to combat CVD in Europe.
A study found that heart attack mortality rates have not declined despite a significant reduction in door-to-balloon time, highlighting the need for further strategies to improve care. The analysis of 100,000 heart attack admissions revealed that faster treatment times did not lead to better patient outcomes.
A study suggests that Abbott's high sensitive troponin test can improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack, particularly in women. Women are often under-diagnosed due to lower levels of cardiac troponin, which can contribute to delayed treatment.
Researchers successfully resynchronized cardiac motion following a heart attack using engineered stem cells, preventing heart failure. The breakthrough introduces 'biological resynchronization' as a novel means to treat cardiac dyssynchrony.
The smart phone app uses data from over 100,000 heart attack patients to calculate the risk of repeat attacks within three years. This enables clinicians to tailor treatments to individual patients, reducing the risk of side effects and improving patient outcomes.
A study published in the Journal of the American Medical Association found that otamixaban, a novel anticoagulant, did not reduce ischemic events but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention (PCI). The trial compared otamixaban with unfraction...
The TASTE trial found that aspiration of the blood clot causing a heart attack does not improve survival rates compared to balloon dilation and stenting alone. The study enrolled over 7,200 patients with ST-elevation myocardial infarction (STEMI) from Sweden, Denmark, and Iceland.
A recent study published by the European Society of Cardiology found that quitting smoking reduces the risk of heart attacks and death to levels seen in never smokers. However, it does not reduce the presence or severity of coronary artery disease (CAD). The study examined over 13,000 patients from around the world and found that activ...
Research published in the journal Heart suggests that flu jab reduces heart attack risk by 45% in middle-aged individuals with narrowed arteries. The study found that flu was an underlying cause of heart attacks in hospital patients, and that vaccination may be protective.
Researchers used clustering techniques to analyze 300 patient cases and identify specific risk factors associated with heart attack risk. Key findings include the importance of age, gender, and lifestyle habits in determining cardiac risk levels.
A new study suggests that a half-dose of prasugrel, an anti-platelet drug used to treat heart attacks, works as well as the typical dosage in older patients over 75. The research found no greater risk of bleeding problems with a lower dose of 5-mg/day prasugrel compared to the standard 75-mg clopidogrel dosage.
A BIDMC research team will assess the use of microRNAs as biomarkers in predicting complications in patients who have suffered heart attacks. The goal is to identify microRNA biomarkers that can predict poor health outcomes after heart attacks.
The study found that the number of individuals with PAD has increased by over 28% globally since 2000, driven by longer life expectancy and changing lifestyles. The researchers identified key risk factors for PAD, including smoking, diabetes, hypertension, and high cholesterol.
Coronary artery disease (CAD) disproportionately affects women, with unique risk factors including pregnancy and autoimmune diseases. Women are more likely to die from CAD than men in similar circumstances, especially at younger ages.
High platelet reactivity after drug-eluting stent implantation was associated with increased risk of stent thrombosis and heart attack, while also reducing major bleeding. However, the association between high platelet reactivity and mortality was not independent.
A study of 26,902 male health professionals found that skipping breakfast was associated with a 27% increased risk of heart attack or death from coronary heart disease. Men who reported eating late at night also had a higher risk of coronary heart disease, but this may not be a major public health concern due to low prevalence in the s...
Researchers used near-infrared spectroscopy to detect lipid core plaque in narrowed arteries of 20 patients experiencing a STEMI. The study found that the characteristic makeup of arterial plaque blocking an artery and causing a heart attack can be identified in living patients.
Researchers found that participants with cheerful temperaments had a one-third reduction in coronary events, with those at highest risk experiencing nearly a 50% decrease. The study's findings suggest a general sense of well-being can have an actual effect on disease and may lead to better health outcomes.
A new study suggests that implementing smoke-free laws and increasing tobacco taxes in India can reduce cardiovascular disease deaths, potentially preventing 9 million deaths by 2022. The findings are based on a mathematical model that considered unique populations with different risk factors.
Two angiotensin-receptor blockers, telmisartan and valsartan, have been shown to reduce hospitalization for heart attack, stroke, or heart failure in people with type 2 diabetes. Researchers found a lower risk of cardiovascular illnesses associated with these drugs compared to other treatments.
Researchers found that people who believe stress affects their health have double the risk of a heart attack. After adjusting for factors, they still had a 50% greater risk compared to those who didn't perceive stress as affecting their health.
Researchers at Washington University School of Medicine found no link between nitrous oxide anesthesia and increased risk of heart attack. Despite concerns about the impact on homocysteine levels, the study showed that B vitamins did not influence heart attack risk in surgery patients.
Researchers analyzed data from two large clinical trials to investigate the impact of high-dose statins on kidney function. The findings suggest that higher-strength statins do not increase the risk of hospitalizations with kidney injury when compared to low-dose statins.
The average UK salt content of packaged bread fell by 20% from 2001 to 2011, reducing the risk of heart disease and other health problems. Despite this progress, significant variations in salt levels among different products persisted.
A new study found a high prevalence of NSAID prescriptions in patients with ischaemic heart disease or risk factors, highlighting the need for safer alternatives and physician guidelines to prevent cardiovascular harm. Diclofenac was commonly prescribed in 56% of cases, raising concerns about its safety.
A nationwide study in Sweden found that people with Alzheimer's disease taking cholinesterase inhibitors have a 36% lower risk of death, 38% lower risk of heart attack, and 26% lower risk of cardiovascular deaths compared to non-users. Patients on the highest recommended doses had the lowest risk of heart attack or death.
Symptoms of post-traumatic stress disorder (PTSD) following a heart attack are relatively common and associated with poor sleep quality. The study found that survivors with PTSD have a doubled risk of having another cardiac event or dying within one to three years.
Patients with advanced kidney disease undergoing hemodialysis are at high risk of heart attacks due to uremic toxins. New research identifies oral adsorbent AST-120 as a potential treatment to delay kidney disease progression and prevent future heart attacks.
A meta-analysis of 639 trials shows that higher-dose NSAIDs like diclofenac and ibuprofen are associated with increased risks of heart disease and fatal heart attacks. The study suggests that the size of these risks can be predicted, helping physicians choose safer NSAID regimens for patients.
A new experimental iPhone application has been shown to transmit diagnostic heart images faster and with greater reliability than current methods. The app could help save lives by speeding treatment for STEMI, the deadliest type of heart attack.
Researchers found that patients with heart failure and heart attack face a high risk of death and re-hospitalization within the first year after discharge. The risk of re-hospitalization for heart failure takes more than 43 days to decline significantly, highlighting the importance of post-discharge care.
A study published in the Journal of the American Society of Nephrology found that LDL cholesterol is not a reliable indicator of heart disease risk in patients with kidney disease. Patients with very low kidney function were more likely to have a heart attack, regardless of their LDL levels.
A study found that young women are less healthy and have a poorer quality of life prior to a heart attack compared to men of similar age. Researchers also discovered that women are more likely to have conditions associated with heart disease, such as diabetes and depression.
Patients with increasing accumulations of coronary artery calcium were six times more likely to suffer a heart attack or die from heart disease. More frequent monitoring of patients with coronary artery calcium buildups could help determine the risk and give them time to make changes.
Northwestern Medicine researchers developed a proactive risk assessment method to evaluate and improve door-to-balloon time for STEMI patients. By identifying high-risk steps and implementing changes, they achieved significant improvements in door-to-balloon times, with an average reduction of 20 minutes.
Patients who have STEMI heart attacks while hospitalized are at a significantly higher risk of death compared to those treated outside the hospital. The survival rate for inpatients with STEMI is around 60%, while outpatients have a survival rate of over 96%.
A study found low prevalence of healthy lifestyle behaviors, such as regular physical activity and healthy diets, in individuals with CHD or stroke globally. The data suggests that high-income countries have higher rates of cessation from smoking and healthier lifestyles.
The American College of Physicians (ACP) has introduced two evidence-based interventions and two videos to enhance patient-clinician communication in the first year following an acute coronary syndrome (ACS) event. The initiatives aim to improve health outcomes by providing a patient guide, clinician support tool, and video resources.
A randomized trial found that chelation therapy with disodium EDTA modestly reduced the risk of a composite of adverse cardiovascular outcomes, but did not support routine use for treatment of patients who have had a heart attack. The study included 1,708 patients and showed no effect on total mortality.
Researchers found that a patient-preference, centralized depression care approach significantly reduced depressive symptoms and improved health outcomes for heart attack survivors. The study showed that this type of treatment was feasible, effective, and potentially cost-neutral within six months.
Researchers found a strong link between job burnout and coronary heart disease, with the top 20% of burnt-out employees facing a 79% increased risk. Burnout is associated with physical wear and tear, weakening the body's defenses against cardiovascular disease.
A study of over 3.3 million PCI procedures found that major bleeding was associated with significantly increased in-hospital mortality, with an estimated 12% of deaths related to bleeding complications. The researchers suggest that bleeding-related mortality may be modifiable through established strategies.
Researchers found that a clot-busting therapy can benefit some heart attack patients who cannot have immediate angioplasty, reducing all-cause mortality and cardiac rehospitalization. The STREAM trial included 1,915 patients from 15 countries and showed that drug therapy before transfer was at least as effective as angioplasty.
Research presented at the American College of Cardiology's Annual Scientific Session found no significant benefit from high-dose oral vitamins and minerals in reducing recurrent cardiac events. However, combining these supplements with active chelation therapy showed a slight additional benefit.